Antony, France

Frédéric Revah


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Frédéric Revah: Innovator in Pharmaceutical Sciences

Introduction

Frédéric Revah is a notable inventor based in Antony, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of neurodegenerative disorders. With a total of 2 patents, his work has the potential to impact the medical community profoundly.

Latest Patents

Revah's latest patents include innovative pharmaceutical compositions aimed at treating neurodegenerative diseases. One of his inventions focuses on pharmaceutical compositions that act on the p53 protein or its gene, providing methods for treating neurodegenerative disorders. Another significant patent involves a defective adenovirus that comprises a gene coding for glutathione peroxidase, which is crucial for therapeutic applications and corresponding pharmaceutical compositions.

Career Highlights

Throughout his career, Frédéric Revah has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma S.A. and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Revah has collaborated with esteemed colleagues such as Jacques Mallet and Martine Barkats. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Frédéric Revah's contributions to pharmaceutical sciences through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in the treatment of neurodegenerative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…